The 10 Year Outlook for Cystic Fibrosis

Biorh is a curative intent drug for hemophilia. It's going to cost like two million plus, but it's actually attractive economically because pairs are probably made whole in two years or three years. And lastly, let me just give us 10 year outlook, not financially, not on the stocks, but just what are some diseases out there where you see real signs of hope that are coming.